home / stock / labu / labu news


LABU News and Press, Direxion Daily S&P Biotech Bull 3X Shares From 10/03/23

Stock Information

Company Name: Direxion Daily S&P Biotech Bull 3X Shares
Stock Symbol: LABU
Market: NYSE

Menu

LABU LABU Quote LABU Short LABU News LABU Articles LABU Message Board
Get LABU Alerts

News, Short Squeeze, Breakout and More Instantly...

LABU - SPXS In Positive Drift: Leveraged ETFs October Dashboard

2023-10-03 03:15:13 ET Summary Precious metals and semiconductors leveraged ETFs show the largest drifts now. SPXS has a positive drift on one and 12 trailing months. SPXS's drift history and risks in current market conditions are analyzed. Direxion Daily S&P 5...

LABU - Investing In The New Age Of Neuroscience

2023-09-29 23:45:00 ET Summary A combination of public and private investments in neuroscience, government grants, and charitable donations are helping accelerate a wave of advancements and opportunities in neuroscience. Recent clinical trial success for the second significant, di...

LABU - LABU And LABD: Another Attractive Double-Short Pairs Trade

2023-09-29 16:50:34 ET Summary Pairing Direxion Daily's S&P Biotech Bull 3X Shares ETF with their S&P Biotech Bear 3X Shares ETF produces a low volatility couple. Shorting both assets is attractive because leveraged assets erode over time due to their higher beta and inabi...

LABU - Direxion Daily S&P Biotech Bull 3X Shares declares quarterly distribution of $0.0020

2023-09-20 13:58:54 ET More on Direxion Daily S&P Biotech Bull 3x Shares ETF Seeking Alpha’s Quant Rating on Direxion Daily S&P Biotech Bull 3x Shares ETF Dividend scorecard for Direxion Daily S&P Biotech Bull 3x Shares ETF LABU: A Levered ETF Doom...

LABU - Biopharma Bounce-Back: From Policy Pains To Profitable Plains

2023-09-08 00:03:09 ET Summary The recent IRA list of 10 drug publications is not expected to have a significant impact on big pharma stocks in the near term. The legal challenges by big pharma companies against the IRA may derail the implementation of the drug pricing reforms. ...

LABU - SPUU Still In Negative Drift Despite The Market Recovery

2023-08-31 14:31:29 ET Summary Leveraged ETFs often underperform their underlying index due to beta-slippage, roll yield, tracking errors, and management costs. A drift dashboard with 22 of them. Leveraged ETFs in semiconductors show large drifts. We look at the drift hist...

LABU - LABU: A Levered ETF Doomed From The Start

2023-08-20 13:08:38 ET Summary The Direxion Daily S&P Biotech Bull 3x Shares ETF (LABU) is a high-risk, leveraged ETF that aims to yield three times the performance of the S&P Biotechnology Select Industry Index. The biotech sector is known for its volatility, which can si...

LABU - SDS Is A Good Hedging Tool, But Beware Of Whipsaw

2023-08-02 04:00:18 ET Summary A drift watchlist with SDS and 21 other leveraged ETFs. A semiconductors leveraged ETF shows the worst decay. The average decay of SDS is close to zero, but it may be negative during long periods. The ProShares UltraShort S&P500 ETF...

LABU - SPUU And Leveraged ETFs: July Drift Dashboard

2023-07-02 08:15:12 ET Summary Leveraged ETFs have a non-linear and path-dependent behavior. A drift dashboard with 22 of them. Leveraged ETFs in biotechnology and semiconductors show the largest drifts. A closer look at Direxion Daily S&P 500 Bull 2X Shares ETF. ...

LABU - XBI: A Vehicle For The Transformative Benefits Of Artificial Intelligence Within Biotechnology

2023-07-01 04:59:34 ET Summary Artificial Intelligence stands to revolutionize drug discovery and manufacturing in the biotech industry, promising faster, cost-effective processes, which could greatly benefit biotech investors. The SPDR S&P Biotech ETF, an equal-weighted fund ...

Previous 10 Next 10